Cortigent Inc - CRGT Forvard narx/daromad multiplikatori
Neyromuhandislar va miya-kompyuter interfeysi ekspertlaridan iborat barqaror shtat Cortigent, Inc. (CRGT) kompaniyasining texnologik o'sishini ta'minlaydi. Oldingi sotuvlar nisbatidagi narx (price-to-sales) baholash tendentsiyasi kapital kirimlarini tasdiqlaydi va ushbu ko'rsatkich hozirda darajasida turibdi. Bu holat kompaniyaning implant mikroelektronikasi sohasidagi ishonchli brend sifatidagi maqomi, shuningdek, og'ir jarohat olgan bemorlar uchun motorika va ko'rish qobiliyatini tiklash tizimlarini yaratish orqali diversifikatsiyalash bilan qo'llab-quvvatlanadi.
cortigent.com - tahliliy kesimlar va asosiy koʻrsatkichlar (CRGT)
- bozor narxi va tahlilchilarning maqsadli narxlari:
- emitentning bozor qiymati haqida ma'lumotlar:
- biznesning balans baholash tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Cortigent, Inc.|CRGT - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning kapitalga nisbati Cortigent|CRGT - Kompaniyaning umumiy qarzi|Qarzning balans qiymatiga nisbati CRGT|CRGT - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzlari Cortigent|Tezkor likvidlik cortigent.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CRGT - Yakuniy foyda|Prognoz qilingan kelajakdagi foyda Cortigent, Inc.|CRGT - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Prognoz qilingan narxning foydaga nisbati Cortigent|CRGT - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati CRGT|CRGT - Eskirishdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Cortigent|CRGT - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi cortigent.com|CRGT - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Cortigent, Inc.
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning barcha koʻrsatkichlari tahlili:Cortigent Medical (CRGT)
Forward P/S koeffitsienti Cortigent, Inc. kompaniyasining bozor qiymatini kutilayotgan savdo hajmi bilan nisbatda o'lchaydi va o'zgaruvchan moliyaviy sharoitlar hamda subsidiyalar sharoitida biznesning xavfsizlik zaxirasini belgilaydi. Forward price-to-sales baholashini tahlil qilish orqali investor Cortigent, Inc. modeliga bo'lgan ishonch darajalarini kuzatishi mumkin, bu model texnologik ustunlikni va kelajakdagi pul oqimlarining barqarorligini ta'minlovchi neyrointerfeys ishlab chiquvchilari va komplayens ekspertlaridan iborat noyob xodimlar jamoasi tomonidan qo'llab-quvvatlanadi.
Raqobatdosh kompaniyalar tahlili
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|NBIX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|RGC: Forvard narx/daromad multiplikatori|Axsome Corp - Narxning kutilayotgan daromadga nisbati|ACAD (ACADIA Pharmaceuticals) - Forvard narx/daromad multiplikatori|xenon-pharma.com - Sotuvga nisbatan forvard narx|VKTX (Viking Therapeutics, Inc.) - Forvard P/S multiplikatori|Supernus Pharmaceuticals, Inc. (SUPN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Catalyst Pharmaceuticals Inc (CPRX)|Denali Corp - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|BHVN - Forvard narx/daromad multiplikatori|AMLX: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Trevi Therapeutics Inc TRVI|PRAX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Anavex Life Sciences Corp|Narxning prognoz qilingan daromadga nisbati CeriBell, Inc.|PRTA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ALEC|Annexon Biosciences (ANNX) - Prognoz narxning daromadga nisbati|Omeros - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati NGNE (Neurogene Therapeutics)|ACIU - Narxning prognoz qilingan daromadga nisbati|VYGR (voyagertherapeutics.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|NMRA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Scilex Holding (SCLX)|Forvard narx/daromad multiplikatori TVGN|Forvard P/S multiplikatori Alpha Cognition Corp|Narxning prognoz qilingan daromadga nisbati Cognition Therapeutics (CGTX)|IKT (inhibikase.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|Assertio Holdings (ASRT) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Coya - Forvard P/S multiplikatori|Vistagen Therapeutics (VTGN) - Forvard narx/daromad multiplikatori|ovidrx.com (OVID) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati acumenpharm.com (ABOS)|Narxning prognoz qilingan daromadga nisbati CervoMed|ATHE: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori CLNN (Clene Inc.)|Narxning kutilayotgan daromadga nisbati PEPG|Forvard P/S multiplikatori JUNS (Jupiter Neurosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati relmada.com (RLMD)|Annovis Bio - Forvard P/S multiplikatori|Prognoz narxning daromadga nisbati Grace Therapeutics, Inc. (GRCE)|AIFF: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Klotho Neurosciences (KLTO)|Narxning prognoz qilingan daromadga nisbati NeuroSense Therapeutics Ltd|Kapitalizatsiyaning prognoz qilingan daromadga nisbati RVPH (revivapharma.com)|Forvard narx/daromad multiplikatori MTVA (MetaVia Inc)|Narxning kutilayotgan daromadga nisbati NRXS|Helius Medical Technologies - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PASG|Neuphoria - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati minervaneurosciences.com NERV|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ADXN|ALZN (Alzamend Neuro Inc.) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cyclerion (CYCN)|Forvard narx/daromad multiplikatori PTIX (Protagenic Therapeutics)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati pasitheaclinics.com|Forvard P/S multiplikatori ATXI (Avenue Therapeutics, Inc.)|BCLI - Forvard narx/daromad multiplikatori|CARA - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx CHRO (Chromocell)|ELYM: Forvard P/S multiplikatori|Prognoz narxning daromadga nisbati Intra-Cellular Therapies, Inc. ITCI|Forvard narx/daromad multiplikatori LBPH|MRNS (Marinus Pharmaceuticals Inc) - Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|NeuroBo Pharma - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori SAGE (Sage Therapeutics, Inc.)|synaptogen.com (SNPX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|TRVN: Forvard narx/daromad multiplikatori|VIGL - Forvard P/S multiplikatori|Anew Medical (WENA) - Narxning prognoz qilingan daromadga nisbati|Cerevel Corp - Sotuvga nisbatan forvard narx
